[go: up one dir, main page]

UY26405A1 - METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE. - Google Patents

METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.

Info

Publication number
UY26405A1
UY26405A1 UY26405A UY26405A UY26405A1 UY 26405 A1 UY26405 A1 UY 26405A1 UY 26405 A UY26405 A UY 26405A UY 26405 A UY26405 A UY 26405A UY 26405 A1 UY26405 A1 UY 26405A1
Authority
UY
Uruguay
Prior art keywords
tetrahydrotetraline
ceto
evil
propylamine
administration
Prior art date
Application number
UY26405A
Other languages
Spanish (es)
Inventor
Dijkstra Durk
Meltzer Leonard
Venhuis Bastiaan
Wikstrom Hakan
Wise Lawrence
Wustrow Davied
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to UY26405A priority Critical patent/UY26405A1/en
Publication of UY26405A1 publication Critical patent/UY26405A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El mal de parkinson se trata con un compuesto de la fórmula (I) o una sal farmacéuticamente aceptable del mismo.Parkinson's disease is treated with a compound of formula (I) or a pharmaceutically acceptable salt thereof.

UY26405A 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE. UY26405A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26405A UY26405A1 (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26405A UY26405A1 (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.

Publications (1)

Publication Number Publication Date
UY26405A1 true UY26405A1 (en) 2001-03-16

Family

ID=38812268

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26405A UY26405A1 (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.

Country Status (1)

Country Link
UY (1) UY26405A1 (en)

Similar Documents

Publication Publication Date Title
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
NO2012015I1 (en) Dapoxetine in any form protected by base patent No. 330562
CO5280060A1 (en) BICYCLE AMINO ACIDS AS PHARMACEUTICAL AGENTS
CO5690131A1 (en) DERIVATIVES OF ETER BIARILICO PRESENTING ACTIVITY AS INHIBITORS OF THE RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS
PA8514401A1 (en) NEW DERIVATIVES OF PIPERAZINA
LU91928I2 (en) Ipilimumab and its pharmaceutically acceptable derivatives (YERVOY®)
HRP20090281T1 (en) 1,2,3,4-TETRASUBSTITUATED INDOL FOR TREATMENT OF RESPIRATORY DISEASES
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
EA200300527A1 (en) NEW TREATMENT METHODS FOR TIRED FOOT SYNDROME
EA200200194A1 (en) ANTAGONISTS OF THE CHEMOKINE RECEPTOR AND METHODS OF THEIR APPLICATION
EA200300544A1 (en) EFFECTIVE ANTI-TUMOR MEDICINE
MX9305248A (en) DIARILPIPERAZINOACETAMIDA COMPOUNDS.
DK1458393T3 (en) Substituted diketopiperazines as oxytocin antagonists
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
MXPA02012730A (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates.
DE60128100D1 (en) ANALGICAL DRUG
ECSP014079A (en) SULFONAMIDE DERIVATIVES
ES2191908T3 (en) 4-AMINOPIRROL (3,2-D) PYRIMIDINS AS ANTAGONISTS OF THE NEUROPEPTIDE RECEPTOR.
UY26405A1 (en) METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.
ECSP003725A (en) METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA
ECSP014078A (en) SULFONAMIDE DERIVATIVES
PA8505301A1 (en) METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) - 5 CETO-2-N- PROPILAMINE - TETRAHYDROTETRALINE
NO20003785L (en) Use of 2-amino-6-trifluoromethoxy-benzothiazole for the prevention or therapy of cerebellum dysfunction

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20120119